Christopher Thomas Scott

ORCID: 0000-0001-6502-1599
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Biomedical Ethics and Regulation
  • Pluripotent Stem Cells Research
  • CRISPR and Genetic Engineering
  • Science, Research, and Medicine
  • Ethics in Clinical Research
  • Biotechnology and Related Fields
  • Intellectual Property and Patents
  • Neuroethics, Human Enhancement, Biomedical Innovations
  • Genetics, Aging, and Longevity in Model Organisms
  • Biomedical and Engineering Education
  • Virus-based gene therapy research
  • Innovation and Socioeconomic Development
  • Ethics and Legal Issues in Pediatric Healthcare
  • Monoclonal and Polyclonal Antibodies Research
  • Health Systems, Economic Evaluations, Quality of Life
  • Reproductive Health and Technologies
  • 3D Printing in Biomedical Research
  • Cancer Genomics and Diagnostics
  • Entrepreneurship Studies and Influences
  • Diverse Research and Applications
  • Health and Medical Research Impacts
  • CAR-T cell therapy research
  • Innovative Microfluidic and Catalytic Techniques Innovation
  • Innovation Policy and R&D
  • Lymphoma Diagnosis and Treatment

Baylor College of Medicine
2014-2024

Baylor University
2010-2019

Institute of Medical Ethics
2014-2018

Harvard University
2017

University of Groningen
2017

University of Chicago
2017

University Medical Center Groningen
2017

Stanford University
2006-2015

Ethics and Public Policy Center
2008-2015

University of British Columbia
2012-2014

Abstract Background Forward-looking, democratically oriented governance is needed to ensure that human genome editing serves rather than undercuts public values. Scientific, policy, and ethics communities have recognized this necessity but demonstrated limited understanding of how fulfill it. The field bioethics has long attempted grapple with the unintended consequences emerging technologies, too often such foresight lacked adequate scientific grounding, overemphasized regulation exclusion...

10.1186/s12910-023-00951-8 article EN cc-by BMC Medical Ethics 2023-09-21

This paper explores the notions of hope and how individual patient autonomy can trump carefully reasoned ethical concerns policies intended to regulate stem cell transplants. We argue that same limits knowledge inform arguments restrain unproven treatments might also undermine our ability comprehensively dismiss or condemn them. Incautiously indiscriminately attitudes may drive critical information data underground, impel patients away from working with clinical researchers, tread needlessly...

10.1080/15265161003728860 article EN The American Journal of Bioethics 2010-05-10

Summary Geron Corporation is a publically traded company that launched phase I clinical trial of human embryonic stem cell-based therapy for spinal cord injury. The enrolled the first patient in October 2010 and stopped 1 year later. fifth had been but not transplanted when announced trial's end. After discussions with staff family, an agreement was reached to add her cohort proceed transplant. Two half years later, research still waiting restart. With this background mind, we discuss major...

10.5966/sctm.2014-0147 article EN cc-by-nc Stem Cells Translational Medicine 2014-10-08

10.1038/nbt0805-915 article EN Nature Biotechnology 2005-07-27

10.1038/nbt0307-287 article EN Nature Biotechnology 2007-03-01

In response to calls for public engagement on human genome editing (HGE), which intensified after the 2018 He Jiankui scandal that resulted in implantation of genetically modified embryos, we detail an anticipatory approach governance HGE. By soliciting multidisciplinary experts' input drivers and uncertainties HGE development, developed a set plausible future scenarios ascertain publics values-specifically, their hopes concerns regarding novel technology its applications. turn, gathered...

10.1093/scipol/scae010 article EN cc-by Science and Public Policy 2024-03-25

Technology transfer offices are ubiquitous institutions within American universities. Most underfunded and understaffed, will never turn a profit, drain limited university resources potentially hinder innovation knowledge transfer. Yet, inexplicably, new continue to be established. This article suggests that the continued hype over rare but lucrative blockbuster patents fuels much of this unnecessary expansion. These offices, essentially mandated discover next big one, tend make poor...

10.1177/097172180901500103 article EN Science Technology and Society 2010-03-01

A study was made of the role scientific information in work a sample technologists British electrical and electronics industry. Interviews lasting up to one hour each were conducted with people sample, using standard set questions. The consisted 1082 127 establishments. term ``technologist'' covered all persons engaged research, those technical qualifications, responsible for planning development work. Among findings are that principal literature studied is supply useful which not being...

10.1109/iret-em.1962.5007664 article EN IRE Transactions on Engineering Management 1962-06-01

10.1038/nbt0905-1037 article EN Nature Biotechnology 2005-08-31
Coming Soon ...